Cargando…
Assessment of Immune Status in Dynamics for Patients with Cancer Undergoing Immunotherapy
Immunotherapy using immune checkpoint inhibitors has revolutionized the treatment, and many types of cancer show a response rate of 20–40% and a significant increase in five-year survival. However, immunotherapy is expensive and may cause serious adverse events. Therefore, a predictive method allowi...
Autores principales: | Xenia Elena, Bacinschi, Nicoleta Gales, Laurentia, Florina Zgura, Anca, Iliescu, Laura, Maricela Anghel, Rodica, Haineala, Bogdan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112935/ https://www.ncbi.nlm.nih.gov/pubmed/34054956 http://dx.doi.org/10.1155/2021/6698969 |
Ejemplares similares
-
A Real-World Study to Compare the Safety and Efficacy of Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir, with or without Ribavirin, in 587 Patients with Chronic Hepatitis C at the Fundeni Clinical Institute, Bucharest, Romania
por: Bacinschi, Xenia, et al.
Publicado: (2022) -
Long-term oncological outcome in patients with cervical cancer after 3 trimodality treatment (radiotherapy, platinum-based chemotherapy, and robotic surgery)
por: Trifanescu, Oana Gabriela, et al.
Publicado: (2021) -
Biomolecular Factors Represented by Bcl-2, p53, and Tumor-Infiltrating Lymphocytes Predict Response for Adjuvant Anthracycline Chemotherapy in Patients with Early Triple-Negative Breast Cancer
por: Bacinschi, Xenia Elena, et al.
Publicado: (2020) -
The Efficacy of Immunotherapy in Long-Term Survival in Non-Small Cell Lung Cancer (NSCLC) Associated with the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
por: Rahnea-Nita, Roxana-Andreea, et al.
Publicado: (2023) -
Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis
por: Ilie, Silvia Mihaela, et al.
Publicado: (2018)